Among patients given immune checkpoint inhibitors in the first-line setting, overall survival was more than twice as long for those with a good versus those with a poor performance status.
Patients who are injured do better when treated at trauma centers.
As critical care medicine advances understanding of ICU survivorship, thoughtful selection of medications is needed.
ACR updated its Lung-RADS to include atypical pulmonary cysts in 2022; there has been little discussion on its impact.
Studying endotypes in sleep apnea, diagnostic testing in ILD, and inhaled corticosteroid use in children.
OSA has been increasingly recognized and studied, but still many patients remain undiagnosed and untreated.
APPs play an integral role in the care and management of patients in the ICU and across the spectrum of health care.
Immunotherapy has transformed the treatment landscape of NSCLC and enhanced survival rates.
Respiratory syncytial virus (RSV) has been increasingly recognized as a prevalent cause of lower respiratory tract infection (LRTI) among adults in the United States.
Interstitial lung diseases (ILDs) are a diverse group of relentlessly progressive fibroinflammatory disorders.
There has been a recent interest in post–intensive care syndrome (PICS), as an increasing number of patients are surviving critical illness.
